Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mersifarma
Sukabumi, West Java, Indonesiamersifarma.com ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
Mersi is a major Indonesian pharmaceutical manufacturer and distributor, especially strong in CNS drugs, and is aligned with international GMP standards; details of specific clinical-stage innovative products or targeted therapeutic results are not disclosed.
- Therapeutic areas
- NeurologyOther
- Modalities
- Small moleculeHealth supplementsBiologic
- Industry
- Biotech
02
Partnerships
Reputable pharmaceutical companies in Indonesia for "Toll Manufacturing" (contract manufacturing)
Beyond the preview
Go deeper on Mersifarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mersifarma.